The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
Abstract
Aims: The protective effect of beta-blockers, ACE inhibitors, and ARBs on anthracycline cardiotoxicity has already been demonstrated, but the effect of aldosterone antagonism, which inhibits the last step of the renin–angiotensin–aldosterone system (RAAS), was questioned. This study sought to investigate whether spironolactone protects the heart against anthracycline-induced cardiotoxicity. Methods and results: Eighty-three female patients who were diagnosed with breast cancer were included in the study. The study population was randomized into spironolactone and control groups. A dose of 25 mg/day spironolactone was administered to the patients in the spironolactone group. There were 43 patients (mean age 50 ± 11 years) in the spironolactone group and 40 patients (mean age 51 ± 10 years) in the control group. LVEF decreased from 67.0 ± 6.1 to 65.7 ± 7.4 (P = 0.094) in the spironolactone group, and from 67.7 ± 6.3 to 53.6 ± 6.8 in the control group (P < 0.001). When the general linear model was applied, the interaction of LVEF decrease between groups was significantly lower in the spironolactone group than in the control group (P < 0.001). The diastolic functional grade of subjects in the spironolactone group was protected (P = 0.096), whereas it deteriorated in the control group (P < 0.001). Conclusion: We showed that spironolactone administration used simultaneously with anthracycline group chemotherapeutics protects both myocardial systolic and diastolic functions. Spironolactone can be used to protect against anthracycline-induced cardiotoxicity. Trial registration: NCT02053974.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Self-citationPitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
The impact of childhood cancer on the United States and the world
Bleyer, W. A. (1990) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.40.6.355 · Cited by 368
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T. (2007) · Hypertension · doi:10.1161/01.hyp.0000255636.11931.a2 · Cited by 362
Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.023 · Cited by 325
Self-citationHayashi, M., Tsutamoto, T., Wada, A., Tsutsui, T., Ishii, C., Ohno, K., Fujii, M., Taniguchi, A., Hamatani, T., Nozato, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068340.96506.0f · Cited by 319
Childhood cancer survival in Europe and the United States
Gatta, G., Capocaccia, R., Coleman, M. P., Ries, L. A. G., & Berrino, F. (2002) · Cancer · doi:10.1002/cncr.10833 · Cited by 258
Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga, C., Beretta, G., Pl, V., Gr, L., Pollini, C., Bonadonna, G., Canetta, R. M., Castellani, R., Villa, E., Cg, G., et al. (1979) · PubMed · Cited by 248
Henderson, I. C., Allegra, J. C., Woodcock, T. M., Wolff, S., Bryan, S., Cartwright, K. J., Dukart, G., & Henry, D. W. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.560 · Cited by 246
Ibrahim, M. A., Ashour, O. M., Ibrahim, Y. F., EL-Bitar, H. I., Gomaa, W. M., & Abdel-Rahim, S. R. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.05.007 · Cited by 126
Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.
Iqbal, M., Dubey, K., Anwer, T., Ashish, A., & Pillai, K. K. (2008) · PubMed · Cited by 115
Enzymatic activation and binding of adriamycin to nuclear DNA.
Sinha, B. K., Trush, M. A., Kennedy, K. A., et al. (1984) · PubMed · Cited by 95
Breed, J. G. S., Zimmerman, A. N. E., Dormans, J. A. M. A., & Pinedo, H. M. (1980) · PubMed · Cited by 94
Schimke, I., Müller, J., Priem, F., Kruse, I., Schön, B., Stein, J., Kunze, R., Wallukat, G., & Hetzer, R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01309-2 · Cited by 66
Wei, Y., Whaley‐Connell, A. T., Habibi, J., Rehmer, J. M., Rehmer, N., Patel, K., Hayden, M., DeMarco, V. G., Ferrario, C. M., Ibdah, J. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.121954 · Cited by 50
Wang, H., Shimosawa, T., Matsui, H., Kaneko, T., Ogura, S., Uetake, Y., Takenaka, K., Yatomi, Y., & Fujita, T. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328300a232 · Cited by 44
Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells
Cruet-Hennequart, S., Prendergast, Á. M., Shaw, G., Barry, F., & Carty, M. P. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1196-5 · Cited by 42
Tüzgen, S., Hanımoğlu, H., Tanrıverdi, T., Kaçıra, T., Sanuş, G. Z., Atukeren, P., Dashti, R., Gümüştaş, K., Canbaz, B., & Kaynar, M. Y. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.11.012 · Cited by 41
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Metadata
- Authors
- Akpek, M., Ozdogru, I., Sahin, O., Inanc, M., Dogan, A., Yazici, C., Berk, V., Karaca, H., Kalay, N., Oguzhan, A., & Ergin, A.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-20
- Volume
- 17
- Issue
- 1
- Pages
- 81-89
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2109634728
- Cited by
- 258
- References
- 24
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.